A review of the clinical experience with CMN-001, a tumor RNA loaded dendritic cell immunotherapy for the treatment of metastatic renal cell carcinoma

Engineering dendritic cells (DCs) to treat cancer is a long sought-after goal for cell-based immunotherapies. In this review, we focus on the experience with CMN-001, formally AGS-003, a DC-based immunotherapy, employing autologous DC electroporated with autologous tumor RNA to treat subjects with m...

Descripción completa

Detalles Bibliográficos
Autores principales: DeBenedette, Mark, Gamble, Alicia, Norris, Marcus, Horvatinovich, Joe, Nicolette, Charles A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Immunotherapy - Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332239/
https://www.ncbi.nlm.nih.gov/pubmed/37387210
http://dx.doi.org/10.1080/21645515.2023.2220629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332239/
https://www.ncbi.nlm.nih.gov/pubmed/37387210
http://dx.doi.org/10.1080/21645515.2023.2220629

Ejemplares similares